| Website | konamedical.com |
| Category | BioTech |
| Phone | 425 558 4616 |
| info@konamedical.com | |
| Employees |
| TOTAL | $40M |
| FUNDING TOTAL | $40M |
| Series C, 5/12 Essex Woodlands Health Ventures Domain Associates Morgenthaler Ventures BioStar Ventures | $30M |
| Series C, 12/12 Essex Woodlands Health Ventures Domain Associates Morgenthaler Ventures Western Technology Investment BioStar Ventures | $10M |
Kona Medical is committed to alleviating the suffering and health risks associated with drug-resistant hypertension with a more effective, less invasive approach to renal artery denervation. The company was founded in 2009 by Michael Gertner, MD, with seed financing from Essex Woodlands. Kona was formed on the basis of combining Dr. Gertner’s inventions in the field with the assets of Therus Corporation, a predecessor company in the field of therapeutic focused ultrasound.